Literature DB >> 18606904

Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.

Hiromitsu Matsui1, Katsuyuki Ando, Hiroo Kawarazaki, Ai Nagae, Megumi Fujita, Tatsuo Shimosawa, Miki Nagase, Toshiro Fujita.   

Abstract

Metabolic syndrome is a highly predisposing condition for cardiovascular disease and could be a cause of excess salt-induced organ damage. Recently, several investigators have demonstrated that salt loading causes left ventricular diastolic dysfunction associated with increased oxidative stress and mineralocorticoid receptor activation. We, therefore, investigated whether excess salt induces cardiac diastolic dysfunction in metabolic syndrome via increased oxidative stress and upregulation of mineralocorticoid receptor signals. Thirteen-week-old spontaneously hypertensive rats and SHR/NDmcr-cps, the genetic model of metabolic syndrome, were fed a normal salt (0.5% NaCl) or high-salt (8% NaCl) diet for 4 weeks. In SHR/NDmcr-cps, salt loading induced severe hypertension, abnormal left ventricular relaxation, and perivascular fibrosis. Salt-loaded SHR/NDmcr-cps also exhibited overproduction of reactive oxygen species and upregulation of mineralocorticoid receptor-dependent gene expression, such as Na(+)/H(+) exchanger-1 and serum- and glucocorticoid-inducible kinase-1 in the cardiac tissue. However, in spontaneously hypertensive rats, salt loading did not cause these cardiac abnormalities despite a similar increase in blood pressure. An antioxidant, tempol, prevented salt-induced diastolic dysfunction, perivascular fibrosis, and upregulation of mineralocorticoid receptor signals in SHR/NDmcr-cps. Moreover, a selective mineralocorticoid receptor antagonist, eplerenone, prevented not only diastolic dysfunction but also overproduction of reactive oxygen species in salt-loaded SHR/NDmcr-cps. These results suggest that metabolic syndrome is a predisposed condition for salt-induced left ventricular diastolic dysfunction, possibly via increased oxidative stress and enhanced mineralocorticoid receptor signals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606904     DOI: 10.1161/HYPERTENSIONAHA.108.111815

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

Review 1.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

Review 2.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 3.  Aldosterone and CKD in metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 4.  Aldosterone blockade in chronic kidney disease: can it improve outcome?

Authors:  Robert D Toto
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

5.  Effects of subacute dietary salt intake and acute volume expansion on diastolic function in young normotensive individuals.

Authors:  Gary S Mak; Heloisa Sawaya; Abigail May Khan; Pankaj Arora; Andrew Martinez; Allicia Ryan; Laura Ernande; Christopher Newton-Cheh; Thomas J Wang; Marielle Scherrer-Crosbie
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-03-20       Impact factor: 6.875

Review 6.  The Role of Aldosterone in Obesity-Related Hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Am J Hypertens       Date:  2016-02-28       Impact factor: 2.689

7.  Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Authors:  Anthony G Garcia; Richard M Wilson; Joline Heo; Namita R Murthy; Simoni Baid; Noriyuki Ouchi; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

8.  Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; E Mitchell Seymour; Robert D Brook; Theodore J Kolias; Samar S Sheth; Hannah R Rosenblum; Joanna M Wells; Alan B Weder
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

Review 9.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

10.  Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Authors:  Yuuri Takeshita; Shogo Watanabe; Takuya Hattori; Kai Nagasawa; Natsumi Matsuura; Keiji Takahashi; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2015-07-09       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.